...
首页> 外文期刊>Oncology reports >The long noncoding RNA FTH1P3 promotes the proliferation and metastasis of cervical cancer through microRNA-145
【24h】

The long noncoding RNA FTH1P3 promotes the proliferation and metastasis of cervical cancer through microRNA-145

机译:长的非编码RNA Fth1p3通过MicroRNA-145促进宫颈癌的增殖和转移

获取原文
获取原文并翻译 | 示例

摘要

Emerging evidence has revealed that long noncoding RNAs (lncRNAs) play crucial roles in the development and progression of tumors. The present study aimed to examine the roles and illustrate the underlying mechanisms of lncRNA ferritin heavy chain 1 pseudogene 3 (FTH1P3) in cervical cancer. The expression of lncRNA FTH1P3 and microRNA-145 (miRNA-145 or miR-145) in human cervical cancer samples and cervical cancer cell lines was detected by qRT-PCR (reverse transcription-quantitative polymerase chain reaction). FTH1P3 overexpression, siRNA plasmid, hsa-miR-145 mimic or hsa-miR-145 inhibitor were transfected. The target of FTH1P3 was predicted by bioinformatics analysis and validated by luciferase assay. Statistical significance analysis was performed by SPSS software. The results revealed that FTH1P3 was significantly upregulated in cervical cancer tissues compared with normal tissues. Increased expression of FTH1P3 was revealed in human cervical cancer cell lines compared with cervical normal epithelial cells. Downregulation of FTH1P3 inhibited cell proliferation, invasion and migration, and promoted apoptosis in cervical cancer cells. miR-145 was predicted and validated as a direct target of FTH1P3. Moreover, FTH1P3 siRNA partially attenuated the effects of the miR-145 inhibitor on cell viability and mobility in cervical cancer cells. The present results demonstrated that lncRNA FTH1P3 functioned as a promoting factor in cervical cancer by targeting miR-145.
机译:新兴的证据表明,长度非编码的RNA(LNCRNA)在肿瘤的开发和进展中起着至关重要的作用。本研究旨在探讨宫颈癌LNCRNA铁蛋白重链1伪合霉3(FTH1P3)的潜在机制。通过QRT-PCR(逆转录定量聚合酶链反应)检测人宫颈癌样品和宫颈癌细胞系中LNCRNA FTH1P3和MICRRNA-145(miRNA-145或miR-145)的表达。转染FTH1P3过表达,siRNA质粒,HSA-miR-145模拟物或HSA-miR-145抑制剂。通过生物信息学分析预测FTH1P3的靶标并通过荧光素酶测定验证。 SPSS软件执行统计显着性分析。结果表明,与正常组织相比,宫颈癌组织中FTH1P3显着上调。与宫颈常规上皮细胞相比,人宫颈癌细胞系中揭示了FTH1p3的表达增加。 FTH1P3的下调抑制细胞增殖,侵袭和迁移,促进宫颈癌细胞的凋亡。预测miR-145并验证为Fth1p3的直接目标。此外,FTH1P3 siRNA部分抑制miR-145抑制剂对宫颈癌细胞中细胞活力和迁移率的影响。目前的结果表明,通过靶向miR-145,LNCRNA FTH1P3用作宫颈癌中的促进因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号